Logo Logo
Help
Contact
Switch Language to German

Boscolo, Daria; Kostyleva, Daria; Schuy, Christoph; Weber, Uli; Haettner, Emma; Purushothaman, Sivaji; Dendooven, Peter; Dickel, Timo; Drozd, Vasyl; Franczack, Bernhard; Geissel, Hans; Hornung, Christine; Horst, Felix; Kazantseva, Erika; Kuzminchuk-Feuerstein, Natalia; Lovatti, Giulio; Mukha, Ivan; Nociforo, Chiara; Pietri, Stephane; Pinto, Marco; Reidel, Claire-Anne; Roesch, Heidi; Sokol, Olga; Tanaka, Yoshiki K.; Weick, Helmut; Zhao, Jianwei; Scheidenberger, Christoph; Parodi, Katia and Durante, Marco (2022): Depth dose measurements in water for C-11 and C-10 beams with therapy relevant energies. In: Nuclear Instruments & Methods in Physics Research. Section A - Accelerators Spectrometers Detectors and Associated Equipment, Vol. 1043, 167464

Full text not available from 'Open Access LMU'.

Abstract

Owing to the favorable depth-dose distribution and the radiobiological properties of heavy ion radiation, ion beam therapy shows an improved success/toxicity ratio compared to conventional radiotherapy. The sharp dose gradients and very high doses in the Bragg peak region, which represent the larger physical advantage of ion beam therapy, make it also extremely sensitive to range uncertainties. The use of beta(+) - radioactive ion beams would be ideal for simultaneous treatment and accurate online range monitoring through PET imaging. Since all the unfragmented primary ions are potentially contributing to the PET signal, these beams offer an improved image quality while preserving the physical and radiobiological advantages of the stable counterparts. The challenging production of radioactive ion beams and the difficulties in reaching high intensities, have discouraged their clinical application. In this context, the project Biomedical Applications of Radioactive ion Beams (BARB) started at GSI (Helmholtzzentrum für Schwerionenforschung GmbH) with the main goal to assess the technical feasibility and investigate possible advantages of radioactive ion beams on the pre-clinical level. During the first experimental campaign C-11 and C-10 beams were produced and isotopically separated with the FRagment Separator (FRS) at GSI. The beta(+)-radioactive ion beams were produced with a beam purity of 99% for all the beam investigated (except one case where it was 94%) and intensities potentially sufficient to treat a small animal tumors within few minutes of irradiation time, similar to 10(6) particle per spill for the C-10 and similar to 10(7) particle per spill for the C-11 beam, respectively. The impact of different ion optical parameters on the depth dose distribution was studied with a precision water column system. In this work, the measured depth dose distributions are presented together with results from Monte Carlo simulations using the FLUKA software.

Actions (login required)

View Item View Item